Zachary M Avigan

9PUBLICATIONS
29CO-AUTHORS
Gene and molecular therapyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 08, 2026
Belantamab mafodotin, a BCMA-directed antibody-drug conjugate for multiple myeloma.

|Aug 13, 2025
Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy.

Zachary M Avigan, Jerrel Catlett, Saoirse Bodnar

|Feb 09, 2025
An evaluation of linvoseltamab for treatment of relapsed/refractory multiple myeloma.

Zachary M Avigan, Mohammad A Rattu, Joshua Richter

|Oct 18, 2024
Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma.

Zachary M Avigan, Suzanne Arinsburg, Darren Pan

|Oct 09, 2024
Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival.

Zachary M Avigan, Saoirse Bodnar, Darren Pan

|Jul 31, 2024
Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma.

Zachary M Avigan, Suzanne Arinsburg, Darren Pan

Pageof 2

Frequent Collaborators

4 joint publications

Joshua Richter

2 joint publications

Mohammad A Rattu

2 joint publications

Leora S Boussi

2 joint publications

Santiago Thibaud